Table 1.
Baseline characteristics of hypertensive patients hospitalized for COVID-19 with and without myocardial injury
| Characteristics | Myocardial injury | Fisher’s exact test p-value | |||
|---|---|---|---|---|---|
| No (n = 146) | Yes (n = 47) | ||||
| n | (%) | n | (%) | ||
| Sex | |||||
| Male | 96 | (65.8) | 35 | (74.5) | 0.288 |
| Female | 50 | (34.2) | 12 | (25.5) | |
| Age | |||||
| < 50 years | 56 | (38.4) | 4 | (8.5) | < 0.001 |
| 50 to 69.9 years | 77 | (52.7) | 17 | (36.2) | |
| ≥ 70 years | 13 | (8.9) | 26 | (55.3) | |
| Oxygen Saturation | |||||
| > 93% | 123 | (84.2) | 28 | (59.6) | 0.001 |
| ≤ 93% | 23 | (15.8) | 19 | (40.4) | |
| BMI (kg/m2) | |||||
| < 25 | 13 | (8.9) | 9 | (19.1) | 0.002 |
| 25 a 29.9 | 57 | (39.0) | 23 | (48.9) | |
| ≥ 30.0 | 76 | (52.1) | 10 | (21.3) | |
| Diabetes | |||||
| No | 109 | (74.7) | 24 | (51.1) | 0.004 |
| Yes | 37 | (25.3) | 23 | (48.9) | |
| Cardiac comorbiditiesa | |||||
| No | 136 | (93.2) | 34 | (72.3) | < 0.001 |
| Yes | 10 | (6.8) | 13 | (27.7) | |
| Other comorbiditiesb | |||||
| No | 142 | (97.3) | 38 | (80.9) | 0.001 |
| Yes | 4 | (2.7) | 9 | (19.1) | |
aChronic heart disease, heart failure, and coronary and valvular disease
bChronic lung disease, asthma, and chronic kidney disease
COVID-19, 2019 coronavirus disease; BMI, body mass index